EP 678 A Retrospective Audit of Surveillance Practices of Screen-Detected B3 Lesions in a Tertiary Breast Unit
Clicks: 6
ID: 323873
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
1.5
/100
6 views
5 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #204 of 432 articles by views in the british journal of surgery
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Surveillance of breast lesions with uncertain malignant potential (B3) detected through the NHS breast screening programme (NHSBSP) has been updated. Previous guidelines recommended five-year annual mammography for screen-detected B3 lesions with atypia post-excision - latest guidance replaces this with a return to routine screening. Aims: This audit retrospectively evaluates a breast unit’s practice regarding screen-detected B3 lesions to determine the impact of the new guidance. Methods This registered audit (PLA_54) involved data collection including B3 lesion histopathology and surveillance from electronic records (Cerner) from 1 January to 31 October 2025. Results Prior to the new NHSBSP guidelines, 69 patients with a mean age of 58.9 ± 6.55 years were identified as having screen-detected B3 lesions. 13 patients were excluded from the analysis after vacuum-assisted/surgical excision – 5 patients had cancer and 8 patients self-discharged. Of 56 patients, 53 patients had a vacuum-assisted excision and 3 patients had surgery. Most common initial diagnosis was intraductal papilloma (n=14), complex sclerosing lesion (n=13) and atypical intraductal epithelial proliferation (n=8). 64% (36/56) of patients were referred for five-year annual mammograms. Concordance to mammographic surveillance referrals in the previous NHSBSP guidelines was at 86% (48/56, p>0.05). With the new guidance, 57% (32/56) of patients would not meet the requirements for five-year mammographic surveillance – with a mammographic cost reduction of £288/patient. Conclusion Adherence to historical NHSBSP guidance about annual five-year mammographic surveillance in our tertiary unit prior to introduction of the new guidelines was 86%. Our practice will be re-audited after an educational intervention.
| Reference Key |
openalex_W7172515502
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Chien Lin Soh, Ken Ho, Daniel Leff |
| Journal | the british journal of surgery |
| Year | 2026 |
| DOI |
10.1093/bjs/znag087.642
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.